Clinical trial
18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028
NCT05520255 is registered in ClinicalTrials.gov with University of Alberta as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- 18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028
- Lead sponsor
- University of Alberta
- Phase
- Phase 3
- Overall status
- Recruiting
- Start date
- July 25, 2023
- Completion date
- December 31, 2029
- Enrollment
- 2,800 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
prostate cancer